Search results
Results from the WOW.Com Content Network
Endometrial hyperplasia is a condition of excessive proliferation of the cells of the endometrium, or inner lining of the uterus.. Most cases of endometrial hyperplasia result from high levels of estrogens, combined with insufficient levels of the progesterone-like hormones which ordinarily counteract estrogen's proliferative effects on this tissue.
Cross section through the wall of a hysterectomy specimen of a 30-year-old woman who reported chronic pelvic pain and abnormal uterine bleeding. The endometrial surface is at the top of the image, and the serosa is at the bottom. Misplaced endometrial tissue proliferation in the myometrium causes symptoms through different mechanisms. [6]
An atypical hyperplasia is one with visible abnormalities in the nuclei. Pre-cancerous endometrial hyperplasias are also referred to as endometrial intraepithelial neoplasia. [41] Mutations in the KRAS gene can cause endometrial hyperplasia and therefore Type I endometrial cancer. [37] Endometrial hyperplasia typically occurs after the age of ...
They are a subset of a larger mixed group of lesions previously called "endometrial hyperplasia". [ 2 ] [ 3 ] The EIN diagnostic schema is intended to replace the previous " endometrial hyperplasia " classification as defined by the World Health Organization in 1994, which have been separated into benign (benign endometrial hyperplasia) and ...
Atypical endometrial hyperplasia may represent an early neoplastic process which can lead to endometrial adenocarcinoma. [20] The development of endometrial adenocarcinoma from endometrial hyperplasia is a typical example of how the effects of pathologic hyperplasia can lead to neoplasia, and females who exhibit hyperplasia of the endometrium ...
Megestrol acetate was reported to be effective in the treatment of endometrial hyperplasia in the mid-1960s. [6] It first started to be studied as a treatment for endometrial cancer in 1967, with findings published in 1973. [6] [156] [157] Megestrol acetate was reportedly introduced for the treatment of endometrial cancer in the United States ...
There are a number of indications for obtaining an endometrial biopsy from a non-pregnant woman: [citation needed]. Women with chronic anovulation such as the polycystic ovary syndrome are at increased risk for endometrial problems and an endometrial biopsy may be useful to assess their lining specifically to rule out endometrial hyperplasia or cancer.
The endometrial hyperplasia that leads to endometrial cancer with estrogen therapy can be prevented by concomitant administration of progestogen. [60] The extensive use of high-dose estrogens for birth control in the 1970s is thought to have resulted in a significant increase in the incidence of type 1 endometrial cancer.